Bellevue, Washington Clinical Trials

*Healthy Children Studies

Northwest Clinical Research Center

CRPS Treatment Evaluation 1 Study A Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy and Safety of AXS-02 (Disodium Zoledronate Tetrahydrate) Administered Orally to Subjects with Complex Regional Pain Syndrome Type I (CRPS-I)

Aneurysm

Overlake Hospital Medical Center Updated

Patients are needed to participate in a clinical research study of Penumbra Coil (PC) 400 to evaluate Intracranial Aneurysms

Angina

Research Site Updated

Patients are needed to participate in a clinical research study to evaluate Prevention & Control

Anterior Uveitis

Research Site

A clinical trial to evaluate treatments using 4mg CLS-TA Suprachoriodal Injection and Sham Procedure for patients, Non-Infectious Uveitis

Attention Deficit/Hyperactivity Disorder (ADHD - Pediatric)

Northwest Clinical Research Center

A Randomized, Double-Blind, Placebo-Controlled, Flexible-Dose Titration Study of Methylphenidate Hydrochloride Extended-Release Capsules (Aptensio XR®) in Children Ages 4 to Under 6 Years Diagnosed with Attention Deficit-Hyperactivity Disorder (ADHD)

Autism

Northwest Clinical Research Center

A PHASE II MULTI-CENTER, RANDOMIZED, DOUBLEBLIND, 24-WEEK, 3-ARM, PARALLEL GROUP, PLACEBO-CONTROLLED STUDY TO INVESTIGATE THE EFFICACY AND SAFETY OF RO5285119 IN CHILDREN AND ADOLESCENTS AGE 5-17 WITH AUTISM SPECTRUM DISORDER (ASD)

Bipolar Disorder

Northwest Clinical Research Center

A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP, MULTICENTER, FIXED-DOSE CLINICAL TRIAL EVALUATING THE EFFICACY, SAFETY AND TOLERABILITY OF CARIPRAZINE IN PATIENTS WITH BIPOLAR I DEPRESSION

View More »

Investigative Site 004

Patients are needed to participate in a clinical research study of cariprazine and placebo to evaluate Bipolar Disorder or Depression

Breast Cancer

Overlake Medical Center

A clinical trial to evaluate treatments using BLZ-100 for patients with Solid Tumors

Chronic Back Pain

Northwest Clinical Research Center

A PHASE 3, RANDOMIZED, DOUBLE BLIND, PLACEBO AND ACTIVE-CONTROLLED, MULTICENTER, PARALLEL-GROUP STUDY OF THE ANALGESIC EFFICACY AND SAFETY OF TANEZUMAB IN ADULT SUBJECTS WITH CHRONIC LOW BACK PAIN

Chronic Pain

Northwest Clinical Research Center

CRPS Treatment Evaluation 1 Study A Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy and Safety of AXS-02 (Disodium Zoledronate Tetrahydrate) Administered Orally to Subjects with Complex Regional Pain Syndrome Type I (CRPS-I)

View More »

Research Site Updated

Patients are needed to participate in a clinical research study evaluating AXS-02 (oral zoledronate) and Placebo for the treatment of Chronic Regional Pain Syndrome - Type 1 or Reflex Sympathetic Dystrophy (crps-1)

Northwest Clinical Research Center

A clinical research study of NSAID, Tanezumab 2.5 mg and Tanezumab 5 mg for the treatment of Chronic Pain, Osteoarthritis of the Hip or Knee

Northwest Clinical Research Center Updated

A clinical trial to evaluate treatments for patients with Low Back Pain, Chronic

Constipation

Synergy Pharmaceuticals Inc.

A Phase 3 clinical study for patients with Irritable Bowel Syndrome Characterized by Constipation

COPD (Chronic Obstructive Pulmonary Disease)

Northwest Clinical Research Center

A Randomized, Double-Blind, Parallel Group, Multi-Center Study to Assess the Efficacy and Safety of PT009 Compared to PT005, PT008, and Open-label Symbicort® Turbuhaler®, as an Active Control, on Lung Function over a 24-Week Treatment Period in Subjects With Moderate to Very Severe COPD

View More »

Pearl Investigative Site

A clinical trial seeking patients for a research study for the treatment of Chronic Obstructive Pulmonary Disorder

Pearl Investigative Site

A clinical trial seeking patients for a research study for the treatment of Chronic Obstructive Pulmonary Disorder

Crohn's Disease

Research Site

A clinical research study of Rifaximin Delayed Release (DR) and Placebo for the treatment of Crohn's Disease

Depression

MMG

Does Your Child Have Depression?

View More »

Alkermes Investigational Site

A clinical trial seeking patients for a research study for the treatment of Major Depressive Disorder (MDD)

Forest Investigative Site 001

A clinical research study of Vilazodone, Placebo and Fluoxetine for the treatment of Major Depressive Disorder

Investigative Site 001

A clinical research study of Vilazodone for the treatment of Major Depressive Disorder

Investigative Site 004

Patients are needed to participate in a clinical research study of cariprazine and placebo to evaluate Bipolar Disorder or Depression

Northwest Clinical Research Center

Patients are needed to participate in a clinical research study evaluating CERC-301 and Placebo for the treatment of Major Depressive Disorder (MDD)

Depression (Adolescent)

MMG

Does Your Child Have Depression?

Northwest Clinical Research Center

A Double-blind, Placebo- and Active-Controlled Evaluation of the Safety and Efficacy of Levomilnacipran ER in Adolescent Patients with Major Depressive Disorder

Depression (Major/Severe)

MMG

Does Your Child Have Depression?

Depression (Pediatric)

Northwest Clinical Research Center

A Multicenter, Double-blind, Placebo- and Active-Controlled Parallel-Group Evaluation of the Safety and Efficacy of Vilazodone in Pediatric Patients With Major Depressive Disorder

Depression (Treatment-Resistant)

Northwest Clinical Research Center

A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder

Northwest Clinical Research Center

A Randomized, Double-blind, Active-controlled Trial to Assess the Efficacy and Safety of AXS-05 Administered Orally to Subjects with Treatment Resistant Major Depressive Disorder

Diabetes (Pediatric)

Northwest Clinical Research Center

A Randomized, Double-Blind Study with an Open-Label Extension Comparing the Effect of Once-Weekly Dulaglutide with Placebo in Pediatric Patients with Type 2 Diabetes Mellitus

Diabetes Mellitus, Type 2

Call for Information (Investigational Site 2328) Updated

A clinical trial to evaluate treatments for patients with Type 2 Diabetes Mellitus

Investigational Site Number 8400093 Updated

A clinical research study for the treatment of Type 2 Diabetes Mellitus

Diabetic Macular Edema

Research Site

Patients are needed to participate in a clinical research study evaluating REGN910-3 and Intravitreal Aflibercept Injection (IAI) for the treatment of Diabetic Macular Edema

Fibromyalgia

Northwest Clinical Research Center

A RANDOMIZED, DOUBLE-BLIND, PLACEBOCONTROLLED SAFETY STUDY OF DS-5565 FOR TREATMENT OF PAIN DUE TO FIBROMYALGIA IN SUBJECTS WITH CHRONIC KIDNEY DISEASE

Glaucoma

Speciality Eyecare Centre

Patients are needed to participate in a clinical research study evaluating VS101 Insert Dose A, VS101 Insert Dose B, VS101 Insert Dose C and Latanoprost 0.005% eye drops for the treatment of Open Angle Glaucoma or Ocular Hypertension

Specialty Eye Care

A clinical trial to evaluate treatments using Glaucoma Surgery and InnFocus MicroShunt for patients with Primary Open Angle Glaucoma

Specialty Eyecare Centre

Patients are needed to participate in a clinical research study evaluating Bimatoprost sustained-release, Sham, Timolol and Timolol Vehicle (placebo) for the treatment of Glaucoma, Open-Angle or Ocular Hypertension

Heart Disease

Research Site Updated

Patients are needed to participate in a clinical research study to evaluate Prevention & Control

Hemodialysis

Lake Washington Vascular Center

Patients are needed to participate in a clinical research study evaluating Vonapanitase and Placebo for the treatment of Chronic Kidney Disease (CKD)

Hemorrhage

Lake Washington Vascular Updated

A clinical research study of CELSTAT and Surgicel Original for the treatment of Bleeding Active

Hernia

Overlake Hospital

A clinical study for patients with Hernia, Ventral or Incisional Hernia

High Blood Pressure (Hypertension)

Northwest Clinical Research Center

Multi-center, double-blind, double-dummy, randomized, placebo- and active-reference, parallel group, Phase 2 dose-finding study with ACT-132577 in subjects with essential hypertension (grade 1 and 2)

View More »

Northwest Clinical Research Center

Patients are needed to participate in a clinical research study of Endothelin Receptor Antagonist (ERA), Lisinopril and Placebo to evaluate Essential Hypertension

Speciality Eyecare Centre

Patients are needed to participate in a clinical research study evaluating VS101 Insert Dose A, VS101 Insert Dose B, VS101 Insert Dose C and Latanoprost 0.005% eye drops for the treatment of Open Angle Glaucoma or Ocular Hypertension

Specialty Eyecare Centre

Patients are needed to participate in a clinical research study evaluating Bimatoprost sustained-release, Sham, Timolol and Timolol Vehicle (placebo) for the treatment of Glaucoma, Open-Angle or Ocular Hypertension

Inflammatory Bowel Disease

Research Site

A clinical research study of Rifaximin Delayed Release (DR) and Placebo for the treatment of Crohn's Disease

Kidney Disease

Lake Washington Vascular Center

Patients are needed to participate in a clinical research study evaluating Vonapanitase and Placebo for the treatment of Chronic Kidney Disease (CKD)

Lung Disease

Pearl Investigative Site

A clinical trial seeking patients for a research study for the treatment of Chronic Obstructive Pulmonary Disorder

Pearl Investigative Site

A clinical trial seeking patients for a research study for the treatment of Chronic Obstructive Pulmonary Disorder

Lymphocytic Leukemia, Chronic

Swedish - Bellevue

Clinical trial for Patients with Chronic Lymphocytic Leukemia

Macular Degeneration

Research Site

Patients are needed to participate in a clinical research study evaluating Lampalizumab and Sham for the treatment of Geographic Atrophy

Research Site

A Phase 3 clinical study for patients with Geographic Atrophy

Research Site

A clinical trial to evaluate treatments using E10030, bevacizumab or aflibercept and E10030 sham intravitreal injection for patients with Age-Related Macular Degeneration

Vitreoretinal Associates of Washington

Patients are needed to participate in a clinical research study evaluating abicipar pegol, ranibizumab and sham procedure for the treatment of Macular Degeneration

Macular Edema

Research Site

A clinical trial to evaluate treatments using 4mg CLS-TA Suprachoriodal Injection and Sham Procedure for patients, Non-Infectious Uveitis

Research Site

Patients are needed to participate in a clinical research study evaluating REGN910-3 and Intravitreal Aflibercept Injection (IAI) for the treatment of Diabetic Macular Edema

Migraine and Cluster Headaches

Northwest Clinical Research Center

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients with Chronic Migraine – the REGAIN Study

Northwest Clinical Research Center

A Parallel Group Double-Blind Randomized Placebo Controlled Trial to Evaluate the Efficacy and Safety of ALD403 Administered Intravenously in Patients with Frequent Episodic Migraines

Northwest Clinical Research Center

A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBOCONTROLLED, PARALLEL-GROUP STUDY TO EVALUATE THE EFFICACY, SAFETY, AND TOLERABILITY OF MULTIPLE DOSING REGIMENS OF ORAL AGN-241689 IN EPISODIC MIGRAINE PREVENTION

Northwest Clinical Research Center

A PHASE 3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBOCONTROLLED SINGLE ATTACK STUDY TO EVALUATE THE EFFICACY, SAFETY, AND TOLERABILITY OF ORAL UBROGEPANT IN THE ACUTE TREATMENT OF MIGRAINE

Neoplasm Metastasis

1160.189.10237 Boehringer Ingelheim Investigational Site Updated

Patients are needed to participate in a clinical research study to evaluate Stroke or Secondary Prevention (RE-SPECT ESUS)

Ocular Hypertension

Speciality Eyecare Centre

Patients are needed to participate in a clinical research study evaluating VS101 Insert Dose A, VS101 Insert Dose B, VS101 Insert Dose C and Latanoprost 0.005% eye drops for the treatment of Open Angle Glaucoma or Ocular Hypertension

Specialty Eyecare Centre

Patients are needed to participate in a clinical research study evaluating Bimatoprost sustained-release, Sham, Timolol and Timolol Vehicle (placebo) for the treatment of Glaucoma, Open-Angle or Ocular Hypertension

Osteoarthritis

Northwest Clinical Research Center

A PHASE 3 RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER STUDY OF THE ANALGESIC EFFICACY AND SAFETY OF A DOSE TITRATION REGIMEN FOR THE SUBCUTANEOUS ADMINISTRATION OF TANEZUMAB IN SUBJECTS WITH OSTEOARTHRITIS OF THE HIP OR KNEE

Northwest Clinical Research Center

A PHASE 3 RANDOMIZED, DOUBLE-BLIND, ACTIVE-CONTROLLED, MULTICENTER STUDY OF THE LONG-TERM SAFETY AND EFFICACY OF SUBCUTANEOUS ADMINISTRATION OF TANEZUMAB IN SUBJECTS WITH OSTEOARTHRITIS OF THE HIP OR KNEE

View More »

Northwest Clinical Research Center

A clinical research study of NSAID, Tanezumab 2.5 mg and Tanezumab 5 mg for the treatment of Chronic Pain, Osteoarthritis of the Hip or Knee

Northwest Clinical Research Center

A clinical trial to evaluate treatments using Placebo, Tanezumab 2.5 mg and Tanezumab 2.5mg/5mg for patients with Osteoarthritis, Knee or Osteoarthritis, Hip

Pain

Northwest Clinical Research Center

A PHASE 3, RANDOMIZED, DOUBLE BLIND, PLACEBO AND ACTIVE-CONTROLLED, MULTICENTER, PARALLEL-GROUP STUDY OF THE ANALGESIC EFFICACY AND SAFETY OF TANEZUMAB IN ADULT SUBJECTS WITH CHRONIC LOW BACK PAIN

Northwest Clinical Research Center

CRPS Treatment Evaluation 1 Study A Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy and Safety of AXS-02 (Disodium Zoledronate Tetrahydrate) Administered Orally to Subjects with Complex Regional Pain Syndrome Type I (CRPS-I)

Posterior Uveitis

Research Site

A clinical trial to evaluate treatments using 4mg CLS-TA Suprachoriodal Injection and Sham Procedure for patients, Non-Infectious Uveitis

Postherpetic Neuralgia

Northwest Clinical Research Center

A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Topically Applied TV-45070 (4% and 8% w/w Ointment) in Patients with Postherpetic Neuralgia

View More »

Teva Investigational Site 13081

A clinical trial to evaluate treatments using TV-45070 and Placebo for patients with Postherpetic Neuralgia (PHN)

Schizophrenia and Schizoaffective Disorders

Northwest Clinical Research Center

A Phase 3 Study to Evaluate Weight Gain of ALKS 3831 Compared to Olanzapine in Adults with Schizophrenia

Northwest Clinical Research Center

A 12 WEEK, PHASE 2, RANDOMIZED, DOUBLE-BLIND, PLACEBO CONTROLLED, PARALLEL GROUP STUDY TO EVALUATE THE SAFETY AND EFFICACY OF PF-04958242 IN SUBJECTS WITH COGNITIVE IMPAIRMENT ASSOCIATED WITH SCHIZOPHRENIA (CIAS)

Northwest Clinical Research Center

A phase II randomised, double-blinded, placebo-controlled parallel group trial to examine the efficacy and safety of 4 oral doses of BI 425809 once daily over 12 week treatment period in patients with Schizophrenia

View More »

Alkermes Investigational Site

Patients are needed to participate in a clinical research study of ALKS 3831 and Olanzapine to evaluate Schizophrenia

Stroke

Research Site Updated

Patients are needed to participate in a clinical research study to evaluate Prevention & Control

1160.189.10237 Boehringer Ingelheim Investigational Site Updated

Patients are needed to participate in a clinical research study to evaluate Stroke or Secondary Prevention (RE-SPECT ESUS)

Ulcerative Colitis

Research Site

A clinical trial seeking patients for a research study for the treatment of Ulcerative Colitis

Research Site

A clinical trial to evaluate treatments using etrolizumab for patients with Ulcerative Colitis

Research Site

A Phase 3 clinical study for patients with Ulcerative Colitis

Ulcers

Research Site

A Phase 3 clinical study for patients with Ulcerative Colitis

Research Site

A clinical trial to evaluate treatments using etrolizumab for patients with Ulcerative Colitis

Research Site

A clinical trial seeking patients for a research study for the treatment of Ulcerative Colitis

Uveitis

Research Site

A clinical trial to evaluate treatments using 4mg CLS-TA Suprachoriodal Injection and Sham Procedure for patients, Non-Infectious Uveitis